URMC / Research / Clinical Trials / Study Details

UMMY18121 / Amgen Deno Smol Lipe IIT / Brea Lipe

Research Question:
Is denosumab, delivered as an injection under the skin, safe and well-tolerated in people with smoldering multiple myeloma? And can denosumab reduce the risk of getting multiple myeloma?

Basic Study Information

Purpose:
This study will assess the safety and tolerability of denosumab in smoldering multiple myeloma subjects as well to see if denosumab can reduce subjects' risk of getting multiple myeloma.

Location: University of Rochester Medical Center
Study Reference #: UMMY18121

Lead Researcher (Principal Investigator)

Lead Researcher: Brea Lipe

Study Contact Information

Study Coordinator: Lauren Mitchell
Email: lauren_mitchell@urmc.rochester.edu

Additional Study Details

Contact This Study

First Name *

This field is required

Middle Name

Last Name *

This field is required

Phone Number

I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *

You must agree to be contacted to continue.

Please call me during the day.

Please call me during the evening.

Message

Return to Search

Wilmot Research